 |
PDBsum entry 1vzv
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Serine protease
|
PDB id
|
|
|
|
1vzv
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.21.97
- assemblin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Cleaves -Ala-|-Ser- and -Ala-|-Ala- bonds in the scaffold protein.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
94:2874-2879
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of varicella-zoster virus protease.
|
|
X.Qiu,
C.A.Janson,
J.S.Culp,
S.B.Richardson,
C.Debouck,
W.W.Smith,
S.S.Abdel-Meguid.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Varicella-zoster virus (VZV), an alpha-herpes virus, is the causative agent of
chickenpox, shingles, and postherpetic neuralgia. The three-dimensional crystal
structure of the serine protease from VZV has been determined at 3.0-A
resolution. The VZV protease is essential for the life cycle of the virus and is
a potential target for therapeutic intervention. The structure reveals an
overall fold that is similar to that recently reported for the serine protease
from cytomegalovirus (CMV), a herpes virus of the beta subfamily. The VZV
protease structure provides further evidence to support the finding that herpes
virus proteases have a fold and active site distinct from other serine
proteases. The VZV protease catalytic triad consists of a serine and two
histidines. The distal histidine is proposed to properly orient the proximal
histidine. The identification of an alpha-helical segment in the VZV protease
that was mostly disordered in the CMV protease provides a better definition of
the postulated active site cavity and reveals an elastase-like S' region.
Structural differences between the VZV and CMV proteases also suggest potential
differences in their oligomerization states.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Fig. 4. The catalytic residues (A) in the omit F[o] F[c] map
contoured at 3 . (B) VZV
protease (red) compared with CMV (blue) and trypsin (yellow).
Dashed lines connects the catalytic triad of the VZV protease.
Only CMV numbering is used.
|
 |
Figure 5.
Fig. 5. Molecular surface of the VZV protease looking into
the postulated substrate binding groove. The surface is
color-coded by electrostatic potentials (blue for positive and
red for negative) calculated with the program GRASP (28).
Modeled is the Ala-Ser cleavage site. The red arrow indicates
the position of the scissile^ bond.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
T.Shahian,
G.M.Lee,
A.Lazic,
L.A.Arnold,
P.Velusamy,
C.M.Roels,
R.K.Guy,
and
C.S.Craik
(2009).
Inhibition of a viral enzyme by a small-molecule dimer disruptor.
|
| |
Nat Chem Biol,
5,
640-646.
|
 |
|
|
|
|
 |
S.Laurent,
C.Blondeau,
M.Belghazi,
S.Remy,
E.Esnault,
P.Rasschaert,
and
D.Rasschaert
(2007).
Sequential autoprocessing of Marek's disease herpesvirus protease differs from that of other herpesviruses.
|
| |
J Virol,
81,
6117-6121.
|
 |
|
|
|
|
 |
A.D.Borthwick
(2005).
Design of translactam HCMV protease inhibitors as potent antivirals.
|
| |
Med Res Rev,
25,
427-452.
|
 |
|
|
|
|
 |
A.N.Loveland,
C.K.Chan,
E.J.Brignole,
and
W.Gibson
(2005).
Cleavage of human cytomegalovirus protease pUL80a at internal and cryptic sites is not essential but enhances infectivity.
|
| |
J Virol,
79,
12961-12968.
|
 |
|
|
|
|
 |
E.Jenwitheesuk,
and
R.Samudrala
(2005).
Virtual screening of HIV-1 protease inhibitors against human cytomegalovirus protease using docking and molecular dynamics.
|
| |
AIDS,
19,
529-531.
|
 |
|
|
|
|
 |
A.B.Marnett,
A.M.Nomura,
N.Shimba,
P.R.Ortiz de Montellano,
and
C.S.Craik
(2004).
Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor.
|
| |
Proc Natl Acad Sci U S A,
101,
6870-6875.
|
 |
|
|
|
|
 |
J.Liu,
and
A.Mushegian
(2004).
Displacements of prohead protease genes in the late operons of double-stranded-DNA bacteriophages.
|
| |
J Bacteriol,
186,
4369-4375.
|
 |
|
|
|
|
 |
N.Shimba,
A.M.Nomura,
A.B.Marnett,
and
C.S.Craik
(2004).
Herpesvirus protease inhibition by dimer disruption.
|
| |
J Virol,
78,
6657-6665.
|
 |
|
|
|
|
 |
T.R.Pray,
K.K.Reiling,
B.G.Demirjian,
and
C.S.Craik
(2002).
Conformational change coupling the dimerization and activation of KSHV protease.
|
| |
Biochemistry,
41,
1474-1482.
|
 |
|
|
|
|
 |
H.J.Snijder,
J.H.Van Eerde,
R.L.Kingma,
K.H.Kalk,
N.Dekker,
M.R.Egmond,
and
B.W.Dijkstra
(2001).
Structural investigations of the active-site mutant Asn156Ala of outer membrane phospholipase A: function of the Asn-His interaction in the catalytic triad.
|
| |
Protein Sci,
10,
1962-1969.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.Hara,
M.Shiota,
H.Kido,
Y.Ohtsu,
T.Kashiwagi,
J.Iwahashi,
N.Hamada,
K.Mizoue,
N.Tsumura,
H.Kato,
and
T.Toyoda
(2001).
Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site.
|
| |
Genes Cells,
6,
87-97.
|
 |
|
|
|
|
 |
M.Matsumoto,
S.Misawa,
N.Chiba,
H.Takaku,
and
H.Hayashi
(2001).
Selective nonpeptidic inhibitors of herpes simplex virus type 1 and human cytomegalovirus proteases.
|
| |
Biol Pharm Bull,
24,
236-241.
|
 |
|
|
|
|
 |
R.Batra,
R.Khayat,
and
L.Tong
(2001).
Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease.
|
| |
Nat Struct Biol,
8,
810-817.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Khayat,
R.Batra,
M.J.Massariol,
L.Lagacé,
and
L.Tong
(2001).
Investigating the role of histidine 157 in the catalytic activity of human cytomegalovirus protease.
|
| |
Biochemistry,
40,
6344-6351.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.A.Janson,
A.K.Konstantinidis,
J.T.Lonsdale,
and
X.Qiu
(2000).
Crystallization of Escherichia coli beta-ketoacyl-ACP synthase III and the use of a dry flash-cooling technique for data collection.
|
| |
Acta Crystallogr D Biol Crystallogr,
56,
747-748.
|
 |
|
|
|
|
 |
K.K.Reiling,
T.R.Pray,
C.S.Craik,
and
R.M.Stroud
(2000).
Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements.
|
| |
Biochemistry,
39,
12796-12803.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Tong,
C.Qian,
M.J.Massariol,
R.Déziel,
C.Yoakim,
and
L.Lagacé
(1998).
Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
|
| |
Nat Struct Biol,
5,
819-826.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.H.Liang,
K.A.Brun,
J.A.Feild,
K.O'Donnell,
M.L.Doyle,
S.M.Green,
A.E.Baker,
M.N.Blackburn,
and
S.S.Abdel-Meguid
(1998).
Site-directed mutagenesis probing the catalytic role of arginines 165 and 166 of human cytomegalovirus protease.
|
| |
Biochemistry,
37,
5923-5929.
|
 |
|
|
|
|
 |
S.S.Hoog,
W.W.Smith,
X.Qiu,
C.A.Janson,
B.Hellmig,
M.S.McQueney,
K.O'Donnell,
D.O'Shannessy,
A.G.DiLella,
C.Debouck,
and
S.S.Abdel-Meguid
(1997).
Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex.
|
| |
Biochemistry,
36,
14023-14029.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |